Fig. 4From: Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agentsThe NSCLC, colorectal, and prostate introduced selected proteins with their respective overexpression percentage as potential targets for drug development. These targets introduced due to their high overexpression which make them more desirable agents for cancer treatmentBack to article page